Tempest Therapeutics, Inc. (TPST): Net Income
-$26.26M
Year ended 2025-12-31
-$40.47M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$26.26M | n/m | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | -$41.84M | n/m | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | -$29.49M | n/m | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | -$35.71M | n/m | 2024-03-19, From 2022-01-01 |
| 2021-12-31 | -$28.30M | n/m | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | -$19.21M | n/c | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | -$44.57M | n/m | 2021-03-29, From 2019-01-01 |
| 2018-12-31 | -$27.19M | n/m | 2020-03-11, From 2018-01-01 |
| 2017-12-31 | -$84.58M | n/c | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | -$82.26M | n/m | 2018-03-15, From 2016-01-01 |
| 2015-12-31 | -$73.22M | n/m | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | -$49.52M | n/m | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | -$29.04M | n/m | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | -$13.51M | n/a | 2015-03-16, From 2012-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Tempest Therapeutics, Inc. (TPST) | 2025-12-31 | -$26.26M | n/m |
| Lipocine Inc. (LPCN) | 2025-12-31 | -$9.63M | n/m |
| Aditxt, Inc. (ADTX) | 2025-12-31 | -$43.10M | n/m |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | -$11.84M | n/m |
| Mustang Bio, Inc. (MBIO) | 2025-12-31 | -$1.92M | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$16.59M | n/m |
| Anixa Biosciences Inc (ANIX) | 2025-10-31 | -$10.93M | n/m |
| Aprea Therapeutics, Inc. (APRE) | 2025-12-31 | -$12.60M | n/m |
| Reviva Pharmaceuticals Holdings, Inc. (RVPH) | 2025-12-31 | -$19.86M | n/m |
Compare TPST, LPCN, ADTX, IBO side by side · Screen every company in Pharmaceutical Preparations ↗